BackAlar Pharmaceuticals Overview

Alar Pharmaceuticals Net Tangible Assets

Track Alar Pharmaceuticals's net tangible assets ($2.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$2.38B
↓ 2.90% YoYΔ $-71.07M vs prior year quarter

Peer trimmed avg / median

Loading

Alar Pharmaceuticals Net Tangible Assets History

Loading

Alar Pharmaceuticals vs. peers: Net Tangible Assets Comparison

Loading

Alar Pharmaceuticals Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alar Pharmaceuticals (6785.TWO) FAQ

As of the most recent data (June 2026), 6785.TWO shows a net tangible assets of $2.4B. That compares with $2.4B in the prior-year period — down 2.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6785.TWO's net tangible assets is now $2.4B (was $2.4B) — a 2.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Alar Pharmaceuticals is outperforming or lagging.

Tracking 6785.TWO's net tangible assets over time shows whether Alar Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4B That compares with $2.4B in the prior-year period — down 2.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Alar Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $2.4B) with ownership activity and broader fundamentals.